Invesco’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $704K | Buy |
40,301
+2,478
| +7% | +$49.2K | ﹤0.01% | 3010 |
|
|
2025
Q4 | $742K | Sell |
37,823
-71,540
| -65% | -$1.48M | ﹤0.01% | 3040 |
|
|
2025
Q3 | $3.01M | Sell |
109,363
-2,248
| -2% | -$69.2K | ﹤0.01% | 2454 |
|
|
2025
Q2 | $3.41M | Buy |
111,611
+229
| +0.2% | +$6.5K | ﹤0.01% | 2370 |
|
|
2025
Q1 | $3M | Sell |
111,382
-5,006
| -4% | -$158K | ﹤0.01% | 2384 |
|
|
2024
Q4 | $4.18M | Buy |
116,388
+20,882
| +22% | +$781K | ﹤0.01% | 2338 |
|
|
2024
Q3 | $3.62M | Buy |
95,506
+8,874
| +10% | +$365K | ﹤0.01% | 2391 |
|
|
2024
Q2 | $3.92M | Buy |
86,632
+922
| +1% | +$42.4K | ﹤0.01% | 2311 |
|
|
2024
Q1 | $4.16M | Buy |
85,710
+6,150
| +8% | +$301K | ﹤0.01% | 2345 |
|
|
2023
Q4 | $4.26M | Sell |
79,560
-42,525
| -35% | -$2.15M | ﹤0.01% | 2324 |
|
|
2023
Q3 | $7.16M | Buy |
122,085
+7,052
| +6% | +$441K | ﹤0.01% | 1988 |
|
|
2023
Q2 | $7.25M | Buy |
115,033
+50,746
| +79% | +$3.23M | ﹤0.01% | 2035 |
|
|
2023
Q1 | $4.04M | Sell |
64,287
-128,909
| -67% | -$7.69M | ﹤0.01% | 2323 |
|
|
2022
Q4 | $10.3M | Buy |
193,196
+42,845
| +28% | +$2.32M | ﹤0.01% | 1828 |
|
|
2022
Q3 | $8.43M | Sell |
150,351
-4,922
| -3% | -$325K | ﹤0.01% | 1907 |
|
|
2022
Q2 | $11.2M | Sell |
155,273
-4,432
| -3% | -$330K | ﹤0.01% | 1763 |
|
|
2022
Q1 | $12.7M | Buy |
159,705
+4,604
| +3% | +$415K | ﹤0.01% | 1820 |
|
|
2021
Q4 | $15.7M | Buy |
155,101
+9,917
| +7% | +$989K | ﹤0.01% | 1710 |
|
|
2021
Q3 | $13.4M | Sell |
145,184
-19,331
| -12% | -$1.86M | ﹤0.01% | 1828 |
|
|
2021
Q2 | $16.9M | Buy |
164,515
+99,993
| +155% | +$10M | ﹤0.01% | 1731 |
|
|
2021
Q1 | $6.3M | Buy |
64,522
+12,035
| +23% | +$1.1M | ﹤0.01% | 2255 |
|
|
2020
Q4 | $4.05M | Sell |
52,487
-6,510
| -11% | -$504K | ﹤0.01% | 2288 |
|
|
2020
Q3 | $4.34M | Sell |
58,997
-18,259
| -24% | -$1.46M | ﹤0.01% | 2076 |
|
|
2020
Q2 | $5.67M | Buy |
77,256
+15,410
| +25% | +$1.21M | ﹤0.01% | 1931 |
|
|
2020
Q1 | $3.57M | Buy |
61,846
+27,024
| +78% | +$1.88M | ﹤0.01% | 2075 |
|
|
2019
Q4 | $2.73M | Sell |
34,822
-3,060
| -8% | -$225K | ﹤0.01% | 2506 |
|
|
2019
Q3 | $2.59M | Sell |
37,882
-14,526
| -28% | -$975K | ﹤0.01% | 2495 |
|
|
2019
Q2 | $4.16M | Buy |
52,408
+35,443
| +209% | +$2.81M | ﹤0.01% | 2285 |
|
|
2019
Q1 | $1.42M | Sell |
16,965
-9,881
| -37% | -$1.03M | ﹤0.01% | 2817 |
|
|
2018
Q4 | $3.16M | Sell |
26,846
-15,287
| -36% | -$1.77M | ﹤0.01% | 2240 |
|
|
2018
Q3 | $5.08M | Buy |
42,133
+1,226
| +3% | +$152K | ﹤0.01% | 2134 |
|
|
2018
Q2 | $4.72M | Buy |
40,907
+26,580
| +186% | +$2.91M | ﹤0.01% | 2174 |
|
|
2018
Q1 | $1.23M | Buy |
14,327
+219
| +2% | +$17K | ﹤0.01% | 2925 |
|
|
2017
Q4 | $1.04M | Sell |
14,108
-45
| -0.3% | -$3.01K | ﹤0.01% | 2988 |
|
|
2017
Q3 | $817K | Buy |
14,153
+1,133
| +9% | +$66.9K | ﹤0.01% | 3117 |
|
|
2017
Q2 | $835K | Sell |
13,020
-15,467
| -54% | -$953K | ﹤0.01% | 3119 |
|
|
2017
Q1 | $1.64M | Sell |
28,487
-28,347
| -50% | -$1.69M | ﹤0.01% | 2733 |
|
|
2016
Q4 | $3.48M | Buy |
56,834
+48,062
| +548% | +$3.13M | ﹤0.01% | 2211 |
|
|
2016
Q3 | $607K | Buy |
8,772
+1,140
| +15% | +$75.2K | ﹤0.01% | 3190 |
|
|
2016
Q2 | $425K | Sell |
7,632
-234
| -3% | -$14.1K | ﹤0.01% | 3305 |
|
|
2016
Q1 | $478K | Sell |
7,866
-167,110
| -96% | -$9.84M | ﹤0.01% | 3275 |
|
|
2015
Q4 | $11.2M | Buy |
174,976
+37,968
| +28% | +$2.46M | ﹤0.01% | 1426 |
|
|
2015
Q3 | $9.18M | Buy |
137,008
+28,840
| +27% | +$2.04M | ﹤0.01% | 1495 |
|
|
2015
Q2 | $7.39M | Buy |
108,168
+41,656
| +63% | +$2.64M | ﹤0.01% | 1716 |
|
|
2015
Q1 | $3.69M | Buy |
66,512
+2,258
| +4% | +$116K | ﹤0.01% | 2185 |
|
|
2014
Q4 | $3.3M | Buy |
64,254
+57,442
| +843% | +$2.82M | ﹤0.01% | 2200 |
|
|
2014
Q3 | $251K | Sell |
6,812
-24,546
| -78% | -$886K | ﹤0.01% | 3578 |
|
|
2014
Q2 | $1.23M | Sell |
31,358
-1,764
| -5% | -$65.5K | ﹤0.01% | 2893 |
|
|
2014
Q1 | $1.25M | Buy |
33,122
+8,792
| +36% | +$307K | ﹤0.01% | 2883 |
|
|
2013
Q4 | $919K | Sell |
24,330
-24,442
| -50% | -$935K | ﹤0.01% | 3140 |
|
|
2013
Q3 | $2.12M | Buy |
48,772
+28,146
| +136% | +$1.13M | ﹤0.01% | 2505 |
|
|
2013
Q2 | $746K | Buy |
+20,626
| New | +$627K | ﹤0.01% | 3073 |
|
Other funds holding USNA
NCM
VCM
VPM
Invesco's USNA Position: Q1 2026 in Review
Invesco increased its Usana Health Sciences (USNA) stake by 6.6% in Q1 2026, buying an estimated $49.2K and bringing the position to 40,301 shares worth $704K. The position accounts for ﹤0.01% of the portfolio, ranked #3010.
Invesco first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q2 2021. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Invesco held 40,301 shares of Usana Health Sciences worth $704K as of Q1 2026.
- Invesco bought 2,478 Usana Health Sciences shares in Q1 2026, an estimated $49.2K.
- Usana Health Sciences made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3010 holding.
- Invesco first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
- Invesco's Usana Health Sciences position peaked at $16.9M in Q2 2021.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.